211 related articles for article (PubMed ID: 30123759)
1. Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.
Mishra S; Kritika C; Bajoria AA; Choudhury P; Sahoo SK; Sangamesh NC
J Int Soc Prev Community Dent; 2018; 8(4):289-295. PubMed ID: 30123759
[TBL] [Abstract][Full Text] [Related]
2. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
5. Study of the Role of Salivary Lactate Dehydrogenase in Habitual Tobacco Chewers, Oral Submucous Fibrosis and Oral Cancer as a Biomarker.
Mantri T; Thete SG; Male V; Yadav R; Grover I; Adsure GR; Kulkarni D
J Contemp Dent Pract; 2019 Aug; 20(8):970-973. PubMed ID: 31797856
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Hematological profile in Oral Submucous Fibrosis: A Cross-sectional Study.
Patil DJ; Joshi M
J Oral Maxillofac Pathol; 2020; 24(3):575. PubMed ID: 33967501
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of serum and salivary immunoglobulin G and A levels with total serum protein in oral submucous fibrosis patients: A case control study.
Kandasamy M; Jaisanghar N; Austin RD; Srivastava KC; Anusuya GS; Anisa N
J Pharm Bioallied Sci; 2016 Oct; 8(Suppl 1):S126-S132. PubMed ID: 27829763
[TBL] [Abstract][Full Text] [Related]
8. Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study.
Prasad SR; Pai A; Shyamala K; Yaji A
Microrna; 2020; 9(4):295-302. PubMed ID: 31985389
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cross-sectional thickness and activity of masseter, anterior temporalis and orbicularis oris muscles in oral submucous fibrosis patients and healthy controls: an ultrasonography and electromyography study.
Kant P; Bhowate RR; Sharda N
Dentomaxillofac Radiol; 2014; 43(3):20130016. PubMed ID: 24720604
[TBL] [Abstract][Full Text] [Related]
10. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
11. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
13. Estimation of serum, salivary immunoglobulin G, immunoglobulin A levels and total protein, hemoglobin in smokeless tobacco chewers and oral submucous fibrosis patients.
Balakrishnan C; Aswath N
Contemp Clin Dent; 2015 Sep; 6(Suppl 1):S157-62. PubMed ID: 26604567
[TBL] [Abstract][Full Text] [Related]
14. Estimation of serum immunoglobulin G and immunoglobulin A levels in oral submucous fibrosis patients.
Swami AN; Kale LM; Choudhary SH; Singh AK; Aldhuwayhi SD; Thakare A
Natl J Maxillofac Surg; 2022; 13(1):67-71. PubMed ID: 35911796
[TBL] [Abstract][Full Text] [Related]
15. Salivary malondialdehyde in oral submucous fibrosis - A marker for oxidative damage.
Ganta SR; Chittemsetti S; Sravya T; Guttikonda VR
J Oral Maxillofac Pathol; 2021; 25(1):82-87. PubMed ID: 34349416
[TBL] [Abstract][Full Text] [Related]
16. Habit History in Oral Submucous Fibrosis: Have We Over Emphasized?
R S; Pai A; Yaji A
Asian Pac J Cancer Prev; 2019 Feb; 20(2):451-455. PubMed ID: 30803207
[TBL] [Abstract][Full Text] [Related]
17. Predictors of the severity of oral submucous fibrosis among gutka consumers: a regression analysis.
Siddiqui HK; Khan FR; Sadiq A; Hashmi U; Qaiser Z
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):690-694. PubMed ID: 34078553
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of micronutrient status in serum and saliva of oral submucous fibrosis patients: A clinicopathological study.
Shetty SR; Babu S; Kumari S; Shetty P; Vijay R; Karikal A
Indian J Med Paediatr Oncol; 2012 Oct; 33(4):224-6. PubMed ID: 23580824
[TBL] [Abstract][Full Text] [Related]
19. Versatility of nasolabial flaps for the management of severe trismus in oral submucous fibrosis.
Balaji SM
Indian J Dent Res; 2016; 27(5):492-497. PubMed ID: 27966506
[TBL] [Abstract][Full Text] [Related]
20. Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study.
Suresh H; Gunasekaran N; James A; Krishnan R; Thayalan DK; Kumar AR
J Oral Maxillofac Pathol; 2022; 26(4):594. PubMed ID: 37082061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
